文献速递胸部肿瘤放疗放疗物理与技术

基于UTCP函数计算NSCLC立体定向放疗的个体化分割方案

Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
PubMed 文献 · Radiat Oncol · 2019-06-20

结果显示所有患者TCP均高于92.0%,3次方案IFR范围为3×10.8 Gy至3×12.5 Gy,4次方案为4×9.2 Gy至4×10.7 Gy,且IFR具有患者特异性。

要点

  • 3次方案IFR为3×10.8 Gy至3×12.5 Gy,4次方案为4×9.2 Gy至4×10.7 Gy。
  • 大肿瘤患者TCP和UTCP较低、分次剂量较小;邻近OAR或RIP高风险者UTCP较低、分次剂量较小。

核心结论

  • 所提出的方法能够预测接受SBRT的NSCLC患者的个体化分割方案(IFR),仍需在临床样本中进一步验证。

研究设计与样本

  • 采用线性二次(LQ)模型转换剂量,以同样方法计算3次方案的IFR。

主要发现

  • 3次方案IFR范围为3×10.8 Gy至3×12.5 Gy,4次方案IFR范围为4×9.2 Gy至4×10.7 Gy。
  • 4例典型肿瘤特征患者显示IFR具有患者特异性并可最大化治疗增益。
  • 大肿瘤患者较低TCP和UTCP,且分次剂量较小。
  • 肿瘤邻近OAR或RIP高风险患者UTCP较低、分次剂量较小。

关键数值与推荐

  • P+函数计算考虑TCP、RIP、CWP和RIRF。
  • 剂量缩放范围为1%至200%,步长1%。
  • 所有患者TCP值高于92.0%。

临床怎么用

  • 该方法可用于预测NSCLC患者SBRT的个体化分割方案,根据肿瘤大小及邻近OAR情况调整分次剂量。

局限性

  • 需在临床样本中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To calculate the individualized fraction regime (IFR) in stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC) patients using the uncomplicated tumor control probability (UTCP, P+) function. METHODS: Thirty-three patients with peripheral lung cancer or lung metastases who had undergone SBRT were analyzed. Treatment planning was performed using the dose regime of 48 Gy in 4 fractions. Dose volume histogram (DVH) data for the gross tumor volume (GTV), lung, chest wall (CW) and rib were exported and the dose bin was multiplied by a certain percentage of the dose in that bin which ranged from 1 to 200% in steps of 1%. For each dose fraction, P+ values were calculated by considering the tumor control probability (TCP), radiation-induced pneumonitis (RIP), chest wall pain (CWP) and radiation-induced rib fracture (RIRF). UTCP values as a function of physical dose were plotted and the maximum P+ values corresponded to the optimal therapeutic gain. The IFR in 3 fractions was also calculated with the same method by converting the dose using the linear quadratic (LQ) model. RESULTS: Thirty-three patients attained an IFR using the introduced methods. All the patients achieved a TCP value higher than 92.0%. The IFR ranged from 3 × 10.8 Gy to 3 × 12.5 Gy for 3 fraction regimes and from 4 × 9.2 Gy to 4 × 10.7 Gy for 4 fraction regimes. Four patients with typical tumor characteristics demonstrated that the IFR was patient-specific and could maximize the therapeutic gain. Patients with a large tumor had a lower TCP and UTCP and a smaller fractional dose than patients with a small tumor. Patients with a tumor adjacent to the organ at risk (OAR) or at a high risk of RIP had a lower UTCP and a smaller fractional dose compared with patients with a tumor located distant from the OAR. CONCLUSIONS: The proposed method is capable of predicting the IFR for NSCLC patients undergoing SBRT. Further validation in clinical samples is required.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Lu JY, Lin PX, Huang BT, et al. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function. Radiat Oncol. 2019. PMID: 31221159. doi:10.1186/s13014-019-1318-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。